Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1067362.RAKkMlqmR8mnDsthU-FBSNioiTOcTnmhyqN2BNY-HqHpA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1067362.RAKkMlqmR8mnDsthU-FBSNioiTOcTnmhyqN2BNY-HqHpA130_assertion type Assertion NP1067362.RAKkMlqmR8mnDsthU-FBSNioiTOcTnmhyqN2BNY-HqHpA130_head.
- NP1067362.RAKkMlqmR8mnDsthU-FBSNioiTOcTnmhyqN2BNY-HqHpA130_assertion description "[Targeting the Vav3 oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1067362.RAKkMlqmR8mnDsthU-FBSNioiTOcTnmhyqN2BNY-HqHpA130_provenance.
- NP1067362.RAKkMlqmR8mnDsthU-FBSNioiTOcTnmhyqN2BNY-HqHpA130_assertion evidence source_evidence_literature NP1067362.RAKkMlqmR8mnDsthU-FBSNioiTOcTnmhyqN2BNY-HqHpA130_provenance.
- NP1067362.RAKkMlqmR8mnDsthU-FBSNioiTOcTnmhyqN2BNY-HqHpA130_assertion SIO_000772 23566222 NP1067362.RAKkMlqmR8mnDsthU-FBSNioiTOcTnmhyqN2BNY-HqHpA130_provenance.
- NP1067362.RAKkMlqmR8mnDsthU-FBSNioiTOcTnmhyqN2BNY-HqHpA130_assertion wasDerivedFrom befree-2016 NP1067362.RAKkMlqmR8mnDsthU-FBSNioiTOcTnmhyqN2BNY-HqHpA130_provenance.
- NP1067362.RAKkMlqmR8mnDsthU-FBSNioiTOcTnmhyqN2BNY-HqHpA130_assertion wasGeneratedBy ECO_0000203 NP1067362.RAKkMlqmR8mnDsthU-FBSNioiTOcTnmhyqN2BNY-HqHpA130_provenance.